Chronic Obstructive Pulmonary Disease
暂无分享,去创建一个
[1] W. Knaus,et al. Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .
[2] D. Felmingham. REVIEW OF THE COMPARATIVE IN VITRO ACTIVITY OF SOME ORAL CEPHALOSPORINS , 1998 .
[3] M. Niederman,et al. The role of bacteria in exacerbations of COPD. A constructive view. , 2000, Chest.
[4] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[5] R. Davies,et al. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. , 1994, The European respiratory journal.
[6] D. Hoban,et al. A Critical Review of the Fluoroquinolones , 2002, Drugs.
[7] S. Quintana,et al. Mortality after hospitalization for COPD. , 2002, Chest.
[8] B. Grant,et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.
[9] F. Speizer,et al. Role of infection in chronic bronchitis. , 1975, The New England journal of medicine.
[10] I. Boldur,et al. Chlamydia pneumoniae Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Analysis of 250 Hospitalizations , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[11] M J Connolly,et al. Quality of life in elderly patients with COPD: measurement and predictive factors. , 1998, Respiratory medicine.
[12] R. Grossman. Guidelines for the treatment of acute exacerbations of chronic bronchitis. , 1997, Chest.
[13] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[14] I. Gregg,et al. A study of infective and other factors in exacerbations of chronic bronchitis , 1980, British Journal of Diseases of the Chest.
[15] J. Fagon,et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.
[16] G. Doern,et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Zalewska-kaszubska,et al. Anti-inflammatory capabilities of macrolides. , 2001, Pharmacological research.
[18] A. Anzueto,et al. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. , 2000, Chest.
[19] C Brennen,et al. Multiply Antibiotic Resistant Gram-Negative Bacilli in a Long Term Care Facility A Case Control Study of Patient rick Factors and Prior Antibiotic Use , 1997, Infection Control & Hospital Epidemiology.
[20] M. Leinonen,et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease , 1997, Epidemiology and Infection.
[21] M. Reed. Clinical pharmacokinetics of amoxicillin and clavulanate. , 1996, The Pediatric infectious disease journal.
[22] F. Speizer,et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.
[23] Fletcher Cm. Chronic bronchitis. Its prevalence, nature, and pathogenesis. , 1959 .
[24] B. Meyboom-de Jong,et al. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. , 1995, Thorax.
[25] J. Bartlett,et al. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. , 2001, Archives of internal medicine.
[26] S. Sethi. Etiology and Management of Infections in Chronic Obstructive Pulmonary Disease , 1999 .
[27] J. M. Harris,et al. Acute infective exacerbations of chronic bronchitis. , 1995, QJM : monthly journal of the Association of Physicians.
[28] J. Hirschmann. Do bacteria cause exacerbations of COPD? , 2000, Chest.
[29] R. Kanner,et al. Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis , 1976, The Journal of infectious diseases.
[30] J. C. Campbell,et al. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. , 1999, The Journal of antimicrobial chemotherapy.
[31] T. Kohyama,et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.
[32] C. A. Phillips,et al. Role of infection in chronic bronchitis. , 1976, The American review of respiratory disease.
[33] A. Hoberman,et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media , 2001, The Pediatric infectious disease journal.
[34] M. Niederman,et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. , 1998, Chest.
[35] M. Leinonen,et al. Infectious etiologies in acute exacerbation of COPD. , 2001, Diagnostic microbiology and infectious disease.
[36] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[37] T. Murphy,et al. Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. , 2002, The Journal of infectious diseases.
[38] D. Figgitt,et al. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections. , 2002, Drugs.
[39] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[40] R. Cohen. Clinical efficacy of cefpodoxime in respiratory tract infection. , 2002, The Journal of antimicrobial chemotherapy.
[41] P. Laippala,et al. Prevalence of chronic obstructive pulmonary disease in elderly Finns. , 1994, Respiratory medicine.
[42] Joan Wilson,et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[43] D. Mannino,et al. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.
[44] A. Lindberg,et al. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay , 1994, Infection and immunity.
[45] N. Anthonisen,et al. Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.
[46] E. Vittinghoff,et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.
[47] J. Ruiz,et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.
[48] R. Grossman,et al. The Chronic Obstructive Pulmonary Disease Exacerbation , 2000, Clinics in Chest Medicine.
[49] Marilyn Roberts,et al. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.
[50] E. R. Mcfadden,et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[51] D. Musher,et al. Development of bactericidal antibody during Branhamella catarrhalis infection. , 1985, The Journal of infectious diseases.
[52] T. Murphy,et al. Analysis of Antigenic Structure and Human Immune Response to Outer Membrane Protein CD of Moraxella catarrhalis , 1999, Infection and Immunity.
[53] D. Mccrory,et al. Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.
[54] R. Rodríguez-Roisín,et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.
[55] D. Nicolau. PHARMACODYNAMIC CONSIDERATIONS IN ORAL CEPHALOSPORIN THERAPY-. IMPLICATIONS FOR SELECTION AND EFFECTIVENESS , 1998 .
[56] D. Musher,et al. Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. , 1983, Annals of internal medicine.
[57] F. Blasi,et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. , 1993, The European respiratory journal.
[58] A. Anzueto,et al. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] T. Murphy,et al. Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review , 2001, Clinical Microbiology Reviews.
[60] A. Torres,et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[61] V. Snow,et al. Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2001, Annals of Internal Medicine.
[62] D. Hornick,et al. Infection of Primary Human Bronchial Epithelial Cells by Haemophilus influenzae: Macropinocytosis as a Mechanism of Airway Epithelial Cell Entry , 1999, Infection and Immunity.
[63] S. Sethi,et al. Acute Exacerbations of Chronic Bronchitis , 2001, Drugs & aging.
[64] T. Murphy,et al. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis , 1997, Infection and immunity.
[65] R. Stockley,et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.
[66] W. Timens,et al. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[67] C. Sanguinetti,et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[68] B. Isalska,et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. , 1999, American journal of respiratory and critical care medicine.
[69] B. Burrows,et al. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. , 1969, The New England journal of medicine.
[70] B. Grant,et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.
[71] R. Davies,et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. , 1995, The European respiratory journal.
[72] J. Dankert,et al. Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity. , 1999, Microbial pathogenesis.
[73] T. Murphy,et al. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. , 1997, The Journal of infectious diseases.
[74] R. Stockley,et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.
[75] R. Bonomo. Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] Scott D. Ramsey,et al. The economic burden of COPD. , 2000 .
[77] T. Murphy,et al. Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.